Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins › Research Explorer

DOI

https://doi.org/10.3390/biomedicines12051007
Final published version

Anna M. Timofeeva
Liliya Sh Shayakhmetova
Artem O. Nikitin
Tatyana A. Sedykh
Andrey L. Matveev
Daniil V. Shanshin
Ekaterina A. Volosnikova
Iuliia A. Merkuleva
Dmitriy N. Shcherbakov
Nina V. Tikunova
Sergey E. Sedykh
Georgy A. Nevinsky

Original language	English
Article number	1007
Journal	Biomedicines
Volume	12
Issue number	5
DOIs	https://doi.org/10.3390/biomedicines12051007
Publication status	Published - 2 May 2024

OECD FOS+WOS

3.01.QA MEDICINE, RESEARCH & EXPERIMENTAL
1.06.CQ BIOCHEMISTRY & MOLECULAR BIOLOGY

Research areas

COVID-19, IgG, N-protein, RBD, SARS-CoV-2, autoimmunity, catalytic antibodies, coronavirus, proteolytic antibodies

ID: 60738941